Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Optimal LDL-C Value Enhancement With Inclisiran in Patients With Multiple Comorbidities in Which There Are Drug-Drug Interactions Limiting LDL-C Lowering

NCT06865885 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06865885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06865885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Optimal LDL-C Value Enhancement With Inclisiran in Patients With Multiple Comorbidities in Which There Are Drug-Drug Interactions Limiting LDL-C Lowering
Lead sponsor
University of California, San Diego
Phase
Phase 4
Overall status
Recruiting
Start date
April 2, 2025
Completion date
March 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic syndrome, drug interactions, ldl-cholersterol lowering, primary prevention